Developmentally induced Mll1 loss reveals defects in postnatal haematopoiesis

被引:54
作者
Gan, T. [1 ]
Jude, C. D. [1 ]
Zaffuto, K. [1 ]
Ernst, P. [1 ,2 ]
机构
[1] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Genet, Hanover, NH 03755 USA
[2] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Microbiol & Immunol, Hanover, NH 03755 USA
关键词
haematopoiesis; MLL; Vav; interferon; stem cells; ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS; TRANSGENIC MICE; MUTANT MICE; IN-VIVO; GENE; DNA; EXPRESSION; BINDING; DOMAIN;
D O I
10.1038/leu.2010.171
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mixed lineage leukemia (MLL) gene is disrupted by chromosomal translocations in acute leukemia, producing a fusion oncogene with altered properties relative to the wild-type gene. Murine loss-of-function studies have shown an essential role for Mll in developing the haematopoietic system, yet studies using different conditional knockout models have yielded conflicting results regarding the requirement for Mll during adult steady-state haematopoiesis. In this study, we used a loxP-flanked Mll allele (Mll F) and a developmentally regulated, haematopoietic-specific VavCre transgene to reassess the consequences of Mll loss in the haematopoietic lineage, without the need for inducers of Cre recombinase. We show that VavCre; Mll mutants exhibit phenotypically normal fetal haematopoiesis, but rarely survive past 3 weeks of age. Surviving animals are anemic, thrombocytopenic and exhibit a significant reduction in bone marrow haematopoietic stem/progenitor populations, consistent with our previous findings using the inducible Mx1Cre transgene. Furthermore, the analysis of VavCre mutants revealed additional defects in B-lymphopoiesis that could not be assessed using Mx1Cre-mediated Mll deletion. Collectively, these data support the conclusion that Mll has an essential role in sustaining postnatal haematopoiesis. Leukemia (2010) 24, 1732-1741; doi:10.1038/leu.2010.171; published online 19 August 2010
引用
收藏
页码:1732 / 1741
页数:10
相关论文
共 36 条
[1]  
ABSHIRE TC, 1992, LEUKEMIA, V6, P357
[2]   Truncation of the MLL gene in exon 5 by gene targeting leads to early preimplantation lethality of homozygous embryos [J].
Ayton, P ;
Sneddon, SF ;
Palmer, DB ;
Rosewell, IR ;
Owen, MJ ;
Young, B ;
Presley, R ;
Subramanian, V .
GENESIS, 2001, 30 (04) :201-212
[3]   Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein [J].
Ayton, PM ;
Chen, EH ;
Cleary, ML .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (23) :10470-10478
[4]   Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2 [J].
Bach, C. ;
Mueller, D. ;
Buhl, S. ;
Garcia-Cuellar, M. P. ;
Slany, R. K. .
ONCOGENE, 2009, 28 (06) :815-823
[5]   TLR ligand-induced type IIFNs affect thymopoiesis [J].
Baron, Marie-Laurence ;
Gauchat, Dominique ;
La Motte-Mohs, Ross ;
Kettaf, Nadia ;
Abdallah, Ali ;
Michiels, Thomas ;
Zuniga-Pflucker, Juan-Carlos ;
Sekaly, Rafick-Pierre .
JOURNAL OF IMMUNOLOGY, 2008, 180 (11) :7134-7146
[6]   Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age [J].
Behm, FG ;
Raimondi, SC ;
Frestedt, JL ;
Liu, Q ;
Crist, WM ;
Downing, JR ;
Rivera, GK ;
Kersey, JH ;
Pui, CH .
BLOOD, 1996, 87 (07) :2870-2877
[7]   From stem cell to T cell: one route or many? [J].
Bhandoola, A ;
Sambandam, A .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (02) :117-126
[8]   Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter [J].
Chen, Michael J. ;
Yokomizo, Tomomasa ;
Zeigler, Brandon M. ;
Dzierzak, Elaine ;
Speck, Nancy A. .
NATURE, 2009, 457 (7231) :887-891
[9]   Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis [J].
Daser, A ;
Rabbitts, TH .
GENES & DEVELOPMENT, 2004, 18 (09) :965-974
[10]   Transgenic mice with hematopoietic and lymphoid specific expression of Cre [J].
de Boer, J ;
Williams, A ;
Skavdis, G ;
Harker, N ;
Coles, M ;
Tolaini, M ;
Norton, T ;
Williams, K ;
Roderick, K ;
Potocnik, AJ ;
Kioussis, D .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (02) :314-325